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INTRODUCTION 
Surveillance screening for hepatocellular carcinoma (HCC) has 
been accepted as standard care for patients with chronic liver dis-
ease who are at risk of developing HCC.1-5 Ultrasonography (US) 
has become an established primary surveillance tool for the de-
tection of HCC, given its non-invasiveness, widespread availabili-
ty, acceptance by patients and physicians, and relatively low cost.
The US features of HCC, other hepatic malignancies such as me-
tastasis or cholangiocarcinoma (CC), and benign lesions such as 
hemangioma have been sporadically described in literature.6-14 
However, there is a lack of uniformity in descriptive terminology 
for US features, which can limit its application. Therefore, the cre-
ation of a lexicon is advocated for better communication of radio-
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Background/Aims: To suggest a lexicon for liver ultrasonography and to identify radiologic features indicative of 
benign or malignant lesions on surveillance ultrasonography.
Methods: This retrospective study included 188 nodules (benign, 101; malignant, 87) from 175 at-risk patients identified 
during surveillance ultrasonography for hepatocellular carcinoma. We created a lexicon for liver ultrasonography 
by reviewing relevant literature regarding the ultrasonographic features of hepatic lesions. Using this lexicon, two 
abdominal radiologists determined the presence or absence of each ultrasonographic feature for the included hepatic 
lesions. Independent factors associated with malignancy and interobserver agreement were determined by logistic 
regression analysis and kappa statistics, respectively.
Results: Larger tumor size (odds ratio [OR], 1.12; 95% confidence interval [CI], 1.06-1.183; P<0.001), multinodular 
confluent morphology (OR, 7.712; 95% CI, 1.053-56.465; P=0.044), thick hypoechoic rim (OR, 5.878; 95% CI, 2.681-12.888; 
P<0.001), and posterior acoustic enhancement (OR, 3.077; 95% CI, 1.237-7.655; P=0.016) were independently associated 
with malignant lesions. In a subgroup analysis of lesions <2 cm, none of the ultrasonographic features were significantly 
associated with malignancy or benignity. Interobserver agreement for morphology was fair (κ=0.36), while those for rim 
(κ=0.427), echogenicity (κ=0.549), and posterior acoustic enhancement (κ=0.543) were moderate.
Conclusions: For hepatic lesions larger than 2 cm, some ultrasonography (US) features might be suggestive of 
malignancy. We propose a lexicon that may be useful for surveillance US. (Clin Mol Hepatol 2017;23:57-65)
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logical features, in order to establish standard terminology for use 
in daily practice and clinical research. In addition, to the best of 
our knowledge, no previous study has investigated the possibility 
of using US features for differentiating between benign and ma-
lignant lesions in a clinical setting of surveillance US for HCC.
The purposes of our study were to propose a lexicon for liver US 
and identify radiological features indicative of benign or malig-
nant lesions during surveillance US.
MATERIAL AND METHODS
Patients
This study was approved by our institutional review board, and 
informed patient consent was not required. Between January 
2008 and December 2014, 8,155 patients at high risk for HCC un-
derwent surveillance US more than once at an academic tertiary 
referral hospital in Seoul, Korea. Liver US and serum alpha feto-
protein (AFP) assay are routinely used in conjunction for HCC sur-
veillance at our institution. Computed tomography (CT) or mag-
netic resonance imaging (MRI) is occasionally performed for the 
purpose of surveillance at the discretion of the clinician. Upon re-
viewing the medical records and imaging data of the 8,155 pa-
tients, 512 patients who were suspected for HCC during surveil-
lance were identified. Of the 512 patients, 337 were excluded for 
the following reasons: suspected HCC was initially identified upon 
CT or MRI instead of US (n=128); the time interval between sur-
veillance US and subsequent CT/MRI was longer than 1 month 
(n=198); images could not be retrieved (n=5); US image quality 
was too poor to allow evaluation (n=4); and hepatic lesions re-
mained indeterminate (n=2). The final study cohort consisted of 
175 patients with 188 nodules (benign, 101; malignant, 87).
Of the 101 benign lesions, while 2 were pathologically con-
firmed to be dysplastic nodules and focal nodular hyperplasia by 
biopsy (n=1, each), the remaining 99 were either not visualized 
(n=54) upon subsequent imaging studies or considered benign 
(n=45) based on the absence of changes in subsequent dynamic 
contrast-enhanced CT or MR images acquired during follow-up 
evaluations for over 2 years. Of the 87 malignant lesions, 85 were 
determined to be HCCs based on pathological findings or visual-
ization of hallmark radiological findings (arterial enhancement 
and venous washout) upon subsequent dynamic imaging studies, 
while 2 were determined to be other hepatic malignancies (patho-
Figure 1. Flow diagram of the patient selection 
process and diagnostic results. HCC, hepatocel-
lular carcinoma; CT, computed tomography; 
MRI, magnetic resonance imaging; US, ultraso-
nography; DN, dysplastic nodule; FNH, focal 
nodular hyperplasia; CC, cholangiocarcinoma; 
cHCC-CC, combined HCC-CC.
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logically diagnosed CC and combined HCC-CC). Schematic repre-
sentation of patient selection and diagnostic results are presented 
in Figure 1.
Clinical and laboratory data and pathology reports of these pa-
tients, including patient demographics, etiology of chronic liver 
disease, serum AFP levels, and pathological findings, were retro-
spectively reviewed. The reference value for serum AFP concentra-
tion used at our institution is <9 ng/mL.
Ultrasonography and image analysis
Abdominal US for HCC surveillance was performed using com-
mercially available ultrasound machines (Pro-Sound Alpha10 or 
Pro-Sound F75, Hitachi Aloka Medical, Tokyo, Japan; ACUSON 
S2000, Siemens Medical Solutions, Mountain View, CA, USA; 
iU22, Philips Medical Systems, Best, The Netherlands) with 5-MHz 
curved-array transducers. Image acquisition was performed accord-
ing to our established protocol. Patients with suspected portal vein 
thrombosis underwent grayscale as well as Doppler imaging.
All US images were retrieved from a Picture Archiving and Com-
munication System (Centricity, Version 2.0, GE Healthcare, Bar-
rington, IL, USA). Two abdominal radiologists (M.S.P. and C.A., 
with 19 and 6 years of experience in acquisition and interpreta-
tion of abdominal US images, respectively) reviewed the literature 
on the US features of hepatic lesions and recorded relevant lexi-
cons to subsequently create our own lexicon, which was applied 
for the evaluation of the cases included in the present study.
Based on the newly defined lexicon, two other abdominal radi-
ologists (J.Y.L. and N.S., with 6 and 7 years of experience in ab-
dominal US) performed blinded and independent reviews of the 
US images included in this study. They also evaluated the back-
ground liver parenchyma to classify it as cirrhotic or non-cirrhotic. 
Prior to the independent review process, they underwent training 
for the use of the lexicon, during which they reviewed 20 cases in 
consensus; these cases were not included for further analysis in 
our study. All US images meant for independent review were de-
identified in a random order by one investigator (C.A.) and trans-
ferred to a separate workstation (Intellispace Portal 5.0, Philips, 
Best, The Netherlands) for blinded evaluation. Data regarding the 
size and number of hepatic lesions were retrieved from prospec-
tive US reports without reevaluation. Following the first indepen-
dent image analysis, the interobserver agreement was evaluated, 
and the two reviewers drew conclusions regarding discordant re-
sults by consensus.
Statistical analysis
Comparison of variables between patients with benign and ma-
lignant hepatic lesions was performed using the Mann-Whitney U 
test for continuous variables and the chi-square or Fisher’s exact 
Table 1. Baseline characteristics of patients 
Variables Benign (n=94) Malignant (n=81) Total (n=175) P-value
Age (years) 54 (27-79) 57 (40-84) 57 (27-84) <0.001
Sex (M/F) 60/34 59/22 119/56 0.255
Etiology of liver disease 0.002
    HBV 56 (59.6) 67 (82.7) 123 (70.3) <0.001
    HCV 16 (17) 9 (11.1) 25 (14.3) 0.861
    NBNC 22 (23.4) 5 (6.2) 27 (15.4) 0.006
AFP (ng/mL) 3.19 (0.68-212.71) 10.27 (1.29-26,249) 4.84 (0.68-26,249) <0.001
Background liver parenchyma 0.302
    Cirrhosis 29 (30.9) 31 (38.3) 60 (34.3)
    Non-cirrhosis 65 (69.1) 50 (61.7) 115 (65.7)
No. of suspicious lesions found on US 0.78
    Solitary 88 (94.5) 75 (91.5) 163 (93.1)
    Two 5 (5.4) 6 (7.3) 11 (6.3)
    Three 0 (0) 1 (1.2) 1 (0.6)
Max. tumor size (cm) 1.8 (0.5-6.9) 3 (1.1-8.2) 2.2 (0.5-8.2) <0.001
Values are presented as median (range) or n (%). Patients with both malignant and benign lesions were grouped under the malignant group. 
M, male; F, female; HBV, hepatitis B virus; HCV, hepatitis C virus; NBNC, non-HBV and non-HCV; AFP, alpha fetoprotein; US, ultrasonography. 
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test for categorical variables. Correlation between US features 
and benignity/malignancy was determined using the chi-square or 
Fisher’s exact test.
The associations between US features and malignancy were de-
termined by univariate and multivariate logistic regression analy-
ses, and odds ratios (ORs) with 95% confidence intervals (CIs) 
were calculated for each of the features. Variables with alpha val-
ues <0.1 in univariate analysis were further evaluated by multi-
variate logistic regression analysis, where, ORs for tumor size and 
AFP were calculated per increments of 1 mm and 10 ng/mL, re-
spectively.
Interobserver agreement was expressed by Cohen’s kappa or 
weighted-kappa coefficient (κ). A kappa statistic value of 0.8-1.0 
was considered to indicate excellent agreement; 0.6-0.79, good 
agreement; 0.40-0.59, moderate agreement; 0.2-0.39, fair agree-
ment; and 0-0.19, poor agreement.15 Two-sided P-values <0.05 
were considered statistically significant. All statistical analyses 
were performed using the SAS 9.2 software (SAS Institute Inc., 
Cary, NC, USA).
RESULTS
Baseline patient characteristics
The demographic characteristics of the 175 patients (male, 119; 
female, 56; median age, 57 years; range, 27-84 years) included in 
this study are shown in Table 1. While 81 patients were diagnosed 
as having HCC or other malignancies, the remaining 94 had only 
benign lesions. Patients with malignant hepatic lesions were older 
(median age, 57 years vs. 54 years; P<0.001), more likely to be 
carriers of hepatitis B virus (HBV; 82.7% vs. 59.6%; P<0.001), 
and exhibited greater maximum lesion diameters (median diame-
ter, 3 cm vs. 1.8 cm; P<0.001) and higher serum AFP levels (medi-
an AFP level, 10.27 ng/mL vs. 3.19 ng/mL; P<0.001) than those 
with benign lesions. There were no significant differences be-
tween the two patient groups in terms of sex (P=0.255), back-
ground liver (P=0.302), or number of suspicious lesions identified 
on surveillance US (P=0.78).
Figure 2. Proposed lexicon for ultrasonographic features with schematic drawings.
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Lexicon for ultrasonographic evaluation of hepatic 
lesions
The schematic drawing and description of our lexicon for liver 
US are presented in Figure 2.
The lexicon has four categories: 
1) Morphology — nodular with indistinct margin, simple nodu-
lar, multinodular confluent, or infiltrative
2) Rim — none, hyperechoic, thin (<2 mm) hypoechoic, or thick 
(≥2 mm) hypoechoic (Figs. 3 and 4)
3) Echogenicity — homogeneously hyperechoic, homogeneous-
ly isoechoic, homogeneously hypoechoic, heterogeneous, or mo-
saic appearance
4) Posterior acoustic enhancement — absent, present, or non-
Figure 4. Hyperechoic rim suggestive of benignity. (A) A 43-year-old man with B-viral liver cirrhosis. A 1.3-cm nodule in S5 exhibited a distinct hyper-
echoic rim with less echogenic portions at the center. The most likely diagnosis of this nodule based on magnetic resonance imaging findings was 
dysplastic nodule, and it exhibited no changes in size or characteristics for over 2 years. (B) A 43-year-old man with chronic hepatitis B. A 2.1-cm hyper-
echoic lesion exhibited a relatively less echogenic area at the center. This nodule exhibited typical imaging features of hemangioma and showed no 
growth for over 2 years.
A B
Figure 3. Thin and thick hypoechoic rims. (A) A 41-year-old man with chronic hepatitis B. A 2.3-cm hyperechoic nodule in S4 of the liver was detected 
on surveillance ultrasonography. The nodule had a sharply demarcated border, causing a thin hypoechoic halo appearance (arrow). Additionally, 
acoustic enhancement was observed posterior to the nodule. Upon magnetic resonance imaging (MRI), the nodule was diagnosed as a hemangioma 
based upon typical imaging features. (B) A 27-year-old man with B-viral liver cirrhosis. A 1-cm hyperechoic nodule was detected in S7 of the liver, with 
a barely recognizable thin hypoechoic halo. The nodule exhibited typical imaging features of hemangioma on computed tomography (CT). (C) A 
56-year-old man with B-viral liver cirrhosis. A 2.1-cm nodule with a relatively thick hypoechoic rim was seen in S8 of the liver. Additionally, posterior 
acoustic enhancement was observed. The nodule was diagnosed as hepatocellular carcinoma based on CT and MRI findings. 
A B C
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assessable (in case of lesions located in the posterior subcapsular 
portions of the liver)
Ultrasonographic features of benign and malignant 
hepatic lesions 
The results of image analysis are presented in Table 2. Benign 
hepatic lesions were more likely to exhibit no rim (P<0.001) and 
homogeneous hyperechogenicity (P<0.001) than malignant le-
sions, while the latter were more likely to exhibit multinodular 
confluent morphology (P=0.02), thick hypoechoic rim (P<0.001), 
heterogeneous echogenicity (P<0.001), mosaic appearance 
(P=0.04), and posterior acoustic enhancement (P<0.001) than 
benign lesions. Interobserver agreement for morphology (κ=0.36) 
was fair, while those for rim (κ=0.427), echogenicity (κ=0.549), 
and posterior acoustic enhancement (κ=0.543) were moderate.
The results of univariate and multivariate logistic regression 
analyses (Table 3) revealed larger tumor size (OR, 1.12; 95% CI, 
1.06-1.183; P<0.001), multinodular confluent morphology (OR, 
7.712; 95% CI, 1.053-56.465; P=0.044), thick hypoechoic rim 
(OR, 5.878; 95% CI, 2.681-12.888; P<0.001), and posterior 
acoustic enhancement (OR, 3.077; 95% CI, 1.237-7.655; P=0.016) 
to be independent factors associated with malignant hepatic le-
sions. None of the US features were significantly associated with 
benign lesions.
 
Subgroup analysis according to tumor size
Prevalence of malignancy according to tumor size is presented 
in Table 4. Of the 188 evaluated lesions, 14 (7.4%) were subcenti-
meter (<1 cm) lesions, 62 (33%) were 1-2 cm in size, 57 (30.3%) 
were 2-3 cm, and 55 (29.3%) were 3 cm or larger. None (0%) of 
the subcentimeter lesions, 14 (22.6%) of the 1-2 cm lesions, 30 
(52.6%) of the 2-3 cm lesions, and 43 (78.2%) of the lesions ≥3 
cm were malignant.
The results of subgroup analysis of lesions <2 cm revealed that 
none of the US features were significantly associated with malig-
nancy or benignity (Table 5). Furthermore, US features favoring ma-
Table 2. Interobserver agreement and frequency of ultrasonographic features in benign and malignant hepatic lesions
Benign (n=101) Malignant (n=87) Total (n=188) P-value
Morphology (κ=0.36)*
Nodular with indistinct margin 36 (35.6) 37 (42.5) 73 (38.8) 0.999
Simple nodular 63 (62.4) 45 (51.7) 108 (57.4) 0.183
Multinodular confluent 0 (0) 5 (5.7) 5 (2.7) 0.02
Infiltrative 2 (2) 0 (0) 2 (1.1) 0.5
Rim (κ=0.427)*
None 71 (70.3) 39 (44.8) 110 (58.5) <0.001
Hyperechoic 5 (5) 1 (1.1) 6 (3.2) 0.219
Thin hypoechoic 15 (14.9) 13 (14.9) 28 (14.9) 0.999
Thick hypoechoic 10 (9.9) 34 (39.1) 44 (23.4) <0.001
Echogenicity (κ=0.549)*
Homogeneously hyperechoic 47 (46.5) 12 (13.8) 59 (31.4) <0.001
Homogeneously isoechoic 9 (8.9) 13 (14.9) 22 (11.7) 0.999
Homogeneously hypoechoic 28 (27.7) 20 (23) 48 (25.5) 0.505
Heterogeneous 17 (16.8) 38 (43.7) 55 (29.3) <0.001
Mosaic appearance 0 (0) 4 (4.6) 4 (2.1) 0.04
Posterior acoustic enhancement (κ=0.543)*
Absent 72 (96) 40 (65.6) 112 (82.4)
Present 3 (4) 21 (34.4) 24 (17.6) <0.001
Non-assessable 26 26 52
Values are presented as n (%). 
*κ indicates kappa statistic for interobserver agreement for qualitative items.
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lignancy were rarely observed in small lesions; among the 14 small 
(<2 cm) malignant lesions, thick hypoechoic rim, heterogeneous 
echogenicity, mosaic appearance, and posterior acoustic enhance-
ment were observed in none or only a couple of cases (Table 5). 
Logistic regression analysis could not be performed because the 
frequencies of potentially significant US features were too low.
DISCUSSION
In the present study, size and three morphological features in-
cluding multinodular confluent morphology, thick hypoechoic rim, 
and posterior acoustic enhancement were found to be significant-
ly associated with malignancy. Multinodular confluent morpholo-
gy, thick hypoechoic rim, and posterior acoustic enhancement 
were reported as morphological features suggestive of malignan-
cy over two decades ago.8,10,12,14 In spite of the recent technologi-
cal developments in US, characteristic features suggestive of ma-
lignancy have remained unchanged. However, in our study, these 
features were mostly observed in large lesions. In addition, in 
case of hepatic lesions <2 cm in size, none of the US features ex-
hibited significant association with benignity or malignancy.
Table 3. Logistic regression analysis of ultrasonographic (US) features associated with benign and malignant hepatic lesions
US feature
Univariate analysis Multivariate analysis
OR 95% CI P-value OR 95% CI P-value
Size* 1.1 1.063-1.139 <0.001 1.12 1.060-1.183 <0.001
Morphology
Nodular with indistinct margin Reference
Simple nodular 1.46 0.898-2.374 0.127
Multinodular confluent 13.265 2.822-62.35 0.001 7.712 1.053-56.465 0.044
Infiltrative 1.561 0.315-7.722 0.585
Rim
None Reference
Hyperechoic 0.324 0.065-1.601 0.167
Thin hypoechoic 1.986 0.961-4.107 0.064 1.552 0.476-5.053 0.466
Thick hypoechoic 5.976 2.735-13.058 <0.001 5.878 2.681-12.888 <0.001
Echogenicity
Homogeneously hyperechoic Reference
Homogeneously isoechoic 0.58 0.241-1.398 0.225
Homogeneously hypoechoic 0.413 0.172-0.991 0.048 1.236 0.343-4.454 0.746
Heterogeneous 0.807 0.362-1.798 0.599
Mosaic appearance 0.741 0.123-4.461 0.743
Posterior acoustic enhancement
Absent or Non-assessable Reference
Present 5.353 2.352-12.184 <0.001 3.077 1.237-7.655 0.016
OR, odds ratio; CI, confidence interval. 
*OR for tumor size was calculated per increment of 1 mm.
Table 4. Prevalence of hepatic malignancy according to tumor size
<1 cm 1-2 cm 2-3 cm ≥3 cm Total (n=188)
Benign   14 (100) 48 (77.4) 27 (47.4) 12 (21.8) 101 (53.7)
Malignant 0 (0) 14 (22.6) 30 (52.6) 43 (78.2) 87 (46.3)
Total   14 (100) 62 (100) 57 (100) 55 (100) 188 (100)
Values are presented as n (%). 
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All the international guidelines clearly state that US is a surveil-
lance tool, not diagnostic.1-5 According to the current guidelines, 
short-term follow-up is recommended for a hepatic lesion smaller 
than 1 cm found on surveillance US, while for a hepatic lesion 
larger than 1 cm, dynamic contrast-enhanced CT or MRI is recom-
mended as a recall policy irrespective of US features. Our results 
support the recommendation by the current guidelines; in our 
study, all of the subcentimeter nodules were benign, and the po-
tential for malignancy increases by more than 20% with the in-
crease in the size of lesions beyond 1 cm, with any US feature un-
able to differentiate between small HCC and benign lesion.
Previous studies reporting that hypoechoic rim is suggestive of 
malignancy have not taken the thickness of the rim into ac-
count.9,10,12 To reflect the evolution of technology, we divided the 
hypoechoic rim category into two subcategories — thin and 
thick. In our study, thick hypoechoic rim was significantly associ-
ated with malignancy, while thin hypoechoic rim exhibited no sig-
nificant association. Thin hypoechoic rims observed around be-
nign lesions are more likely to be pseudo-rims, i.e., Mach bands 
rather than true rims, created because of an optical effect at mar-
gins between areas of different echogenicities.16 In contrast, hy-
perechoic rim with partially hypoechoic internal pattern has been 
reported as being specific for hepatic hemangioma.11,13 In our 
study, 5 of 6 lesions with hyperechoic rims were benign, which 
suggests that hyperechoic rim might be indicative of benign le-
sions; however, the statistical significance of this association 
could not be established in our study, possibly because of the low 
frequency of occurrence of hyperechoic rims.
 A major limitation of this study is that we retrospectively re-
viewed US images acquired by a heterogeneous group of US op-
erators, including inexperienced ones. Therefore, the results of 
our study might not be relevant when prospectively applied in dif-
ferent settings. Another limitation could be that the difference of 
size distribution between benign and malignant lesions, which 
could affect the results. Our results showed that none of the US 
features was found to be significantly associated with benignity 
or malignancy in case of small (<2 cm) hepatic lesions. Among 
the 76 small nodules, only 14 (18.5%) nodules were malignant.
Table 5. Distribution of ultrasonographic (US) features among hepatic lesions <2 cm in size
Benign (n=62) Malignant (n=14) Total (n=76)
Morphology
Nodular with indistinct margin 17 (27.4) 5 (35.7) 22 (28.9)
Simple nodular 45 (72.6) 8 (57.1) 53 (69.7)
Multinodular confluent* 0 (0) 1 (7.1) 1 (1.3)
Infiltrative 0 (0) 0 (0) 0 (0)
Rim
None 45 (72.6) 10 (71.4) 55 (72.4)
Hyperechoic 3 (4.8) 0 (0) 3 (3.9)
Thin hypoechoic 7 (11.3) 4 (28.6) 11 (14.5)
Thick hypoechoic* 7 (11.3) 0 (0) 7 (9.2)
Echogenicity
Homogeneous hyperechoic 36 (58.1) 6 (42.9) 42 (55.3)
Homogeneous isoechoic 2 (3.2) 1 (7.1) 3 (3.9)
Homogeneous hypoechoic 18 (29) 6 (42.9) 24 (31.6)
Heterogeneous 6 (9.7) 1 (7.1) 7 (9.2)
Mosaic appearance 0 (0) 0 (0) 0 (0)
Posterior acoustic enhancement
Absent 50 (98) 10 (83.3) 60 (95.2)
Present* 1 (2) 2 (16.7) 3 (4.8)
Non-assessable 11 2 13
Values are presented as n (%). None of the US features exhibited significant differences in frequency between benign and malignant lesions (P>0.05). 
*Ultrasonographic features that were found to be significantly associated with malignancy by multivariate logistic regression analysis of all tumors irrespective 
of tumor size.
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In conclusion, for hepatic lesions larger than 2 cm, some US 
features might be suggestive of malignancy. We proposed a lexi-
con that may be useful for surveillance US.
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